Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GOREISAN for Heart Failure (GOREISAN-HF) Trial

NCT04691700 is registered in ClinicalTrials.gov with Takeshi Morimoto as lead sponsor.

NCT NCT04691700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04691700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GOREISAN for Heart Failure (GOREISAN-HF) Trial
Lead sponsor
Takeshi Morimoto
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 19, 2021
Completion date
December 31, 2027
Enrollment
1,179 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical trial, edema, heart failure, kampo medicine, traditional japanese medicine